drugset / Trial / NCT00264602
Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer
Phase 1
Active not recruiting
57 enrolled
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center · collabBrigham and Women's Hospital · collabMassachusetts General Hospital · collab
NaSingle-groupOpen-labelDiagnostic
Summary
The primary purpose of this study is to determine if we can identify the first lymph node that drains from the tumor, and thus would be the most likely site for metastatic disease, and remove it for analysis to improve the ability to detect tumor in this node and to remove this additional site that potentially contains tumor cells.
Timeline
- Start
- 2009-02-18
- Primary completion
- 2017-09-01
- Completion
- 2029-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indocyanine Green | Diagnostic / imaging agent | 0.333333 unknown | Other |